• 1
    Borge PAProblems in allergic rhinitis.Arzneim Forsch Drug Res1982; 32: 11991201
  • 2
    Wood RA, Doran TFAtopic disease, rhinitis and conjunctivitis, and upper respiratory infections.Curr Opin Pediatr1995; 7: 615627
  • 3
    Nacleiro RMThe pathopysiology of allergic rhinitis: Impact of therapeutic intervention.J Allergy Clin Inmunol1988; 82: 927934
  • 4
    Foreman JCPeptides and neurogenic inflammation.Br Med Bull1987; 43: 386400
  • 5
    Horak FSeasonal allergic rhinitis: Newer treatment approaches.Drugs1993; 45: 518527
  • 6
    Li CS, Hsu LYHome dampness and childhood respiratory in subtropical climate.Arch Environ Health1996; 51: 4246
  • 7
    Bener A, Galadari I, Naser KAPets, allergy and respiratory symptoms in children living in a desert country.Allerg Immunol Paris1995; 27: 190195
  • 8
    Clissold SP, Sorkin EM, Goa KLLoratadine: A preliminary review of its pharmacodynamic properties and threapeutic efficacy.Drugs1989; 37: 4257
  • 9
    Hoffman BB, Lefkowitz RJCatecholamines, sympathomimetic drugs and adrenergic receptor antagonists. InThe Pharmacological Basis of Therapeutics, Ninth Edition, eds Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, New York: McGraw Hill Company, 1996: 199248
  • 10
    Bronsky EA, Boggs P, Findlay S,et al.Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis.J Allergy Clin Immunol1995; 96: 139147
  • 11
    Grossman J, Bronsky EA, Lainer BQ,et al.Loratadine-pseudoephedrine combination versus placebo in patients with seasonal allergic rhinitis.Ann Allergy1989; 63: 317321
  • 12
    Paz Martinez D, Rosales Parra EEvaluación comparativa del astemizol-pseudoefedrina y loratadina-pseudoefedrina en niños con rinitis alérgica. Rev Alerg Mex1995; 42: 105109
  • 13
    Brody HThe lie that heals: The ethics of giving placebos.Ann Inter Med1982; 97: 112118
  • 14
    Dockhorn RJ, Bergner A, Connell JT,et al.Safety and efficacy of loratadine (Sch-29851): A new non-sedating antihistamine in seasonal allergic rhinitis.Ann Allergy1987; 58: 407411
  • 15
    Gallart TEnfermedades alérgicas mediadas por anticuerpos IgE (hipersensibilidad inmediata o alergia atópica). In Medicina Interna, Twelfth Edition, eds Rozman C, García San Miguel J, Feliu E, Barcelona: Ediciones Doyma, 1992: 26972713
  • 16
    Gutkowsky A, Bedard P, Del Carpio J,et al.Comparison of the efficacy and safety of loratadine, terfenadine, and placebo in the treatment of seasonal allergic rhinitis.J Allergy Clin Immunol1988;81: 902907
  • 17
    Berkowitz RB, Connell JT, Dietz AJ, Greenstein SM, Tilkelman DGThe effectiveness of the non-sedating antihistamine loratadine plus pseudoephedrine in symptomatic management of the common cold.Ann Allergy1989; 63: 336339
  • 18
    Storms WW, Bodman SF, Nathan RA,et al.Sch-434. A new antihistamine/descongestant for seasonal allergic rhinitis.J Allergy Clin Immunol1989; 83: 10831090
  • 19
    Prevost M, Turenne Y, Moote DW,et al.Comparative study of Sch-434 and CTM-D in the treatment of seasonal allergic rhinitis.Clin Ther1994; 16: 5056
  • 20
    Watson WT, Roberts JR, Becker AB, Gendreau-Reid LF, Simons FENasal patency in children with allergic rhinitis: Correlation of objective and subjective assessments.Ann Allergy Asthma Immunol 1995; 74: 237240